Symbol="GANX"
AssetType="Common Stock"
Name="Gain Therapeutics Inc"
Description="Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. The company is headquartered in Bethesda, Maryland."
CIK="1819411"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="44568600"
EBITDA="-22185580"
PERatio="None"
PEGRatio="None"
BookValue="0.878"
DividendPerShare="0"
DividendYield="0"
EPS="-1.57"
RevenuePerShareTTM="0.005"
ProfitMargin="0"
OperatingMarginTTM="-403.64"
ReturnOnAssetsTTM="-0.555"
ReturnOnEquityTTM="-1.158"
RevenueTTM="55180"
GrossProfitTTM="-7660886"
DilutedEPSTTM="-1.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.47"
AnalystTargetPrice="9"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="210.97"
PriceToBookRatio="1.636"
EVToRevenue="85.18"
EVToEBITDA="-0.954"
Beta="0.326"
num_52WeekHigh="6.19"
num_52WeekLow="2.8"
num_50DayMovingAverage="4.367"
num_200DayMovingAverage="4.119"
SharesOutstanding="12328800"
DividendDate="None"
ExDividendDate="None"
symbol="GANX"
open="3.73"
high="3.73"
low="3.53"
price="3.62"
volume="18780.00"
latest_trading_day="2023-08-15"
previous_close="3.74"
change="-0.12"
change_percent="-3.3422%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="37"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="63"
Volume_recent_avg="59606"
Change_recent_avg="-0.01"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="63"
Aroon_momentum_negative="37"
image_negative_thumbnail_id_1="167"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_negative_thumbnail_id_2="1131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="622"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0086.jpeg"
image_positive_thumbnail_id_2="957"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
